NEW YORK, June 17, 2026, 07:07 EDT
- NewGenIVF shares finished Tuesday 20.4% higher at $0.70. MarketBeat showed the stock at $1.07 in extended hours at 7:02 a.m. Eastern.
- The company entered a settlement to buy back convertible notes and warrants from JAK Opportunities VI LLC.
- The deal could ease some dilution, but payments stretch into late 2027. If there’s a default, dilution risk comes back.
Shares of NewGenIVF Group traded higher in premarket action Wednesday. The Bangkok company, listed on Nasdaq, said it will repurchase convertible notes and warrants from a major investor, a move the company said would clear an overhang that has weighed on the stock.
The shares finished Tuesday at $0.70, up 20.4%. By 7:02 a.m. Eastern, MarketBeat data showed them at $1.07 in extended trading. That’s trading that happens outside the regular 9:30 a.m. to 4 p.m. U.S. stock hours—where for smaller names, moves can be sharp but volume thin.
Dilution is the issue here. A convertible note lets debt convert to shares, and warrants give rights to buy shares down the line. Both boost share count and shrink current holders’ stakes. NewGenIVF said the investor agreed not to convert notes, use warrants or seek further closings in earlier securities deals, as long as the company keeps up with settlement payments.
NewGenIVF cut a deal covering senior convertible notes—$475,000 still owed on a 2024 note, and $3.15 million on a 2025 note. The settlement also includes warrants that can become 1,143,208 ordinary shares. The company agreed to pay $7.38 million total: $4.53 million for the notes, $600,000 for the warrants, and $2.25 million in forbearance fees, with payments scheduled through Nov. 1, 2027.
The deal leaves some execution risk in play. The filing notes the forbearance ends if NewGenIVF defaults, allowing the investor’s conversion and exercise rights to return before the buyback finishes. That means shareholders are watching how NewGenIVF handles the payment schedule, not just the headline terms.
Alfred Siu, who founded NewGenIVF and runs the company as chairman and CEO, said the settlement is “a pivotal moment” and said it’s “strengthening our capital structure.” NewGenIVF said the notes will be canceled after the note purchase price is paid in full. The company said the warrants will be canceled once the warrant purchase price gets paid off too.
NewGenIVF is making more changes. Earlier this month, the company said in a statement that it upped its stake in K25.ai to 6% after putting in another $4 million, with the money split between cash and new Class A shares. The firm also said it is moving to a digital asset treasury strategy, so it could start holding things like bitcoin or solana on its balance sheet.
The direct comparison here is limited. Progyny focuses on fertility and family-building benefits. CooperCompanies’ CooperSurgical unit makes fertility and women’s health products. NewGenIVF has been moving on a financing cleanup lately, not due to any new IVF demand signal.
This week is a short one for trading. U.S. stock markets will shut down on Friday, June 19, for Juneteenth, according to Nasdaq’s holiday schedule. That means traders have fewer days to handle settlement before the weekend.
